ALBANY, New York, January 22, 2016 /PRNewswire/ --

In a recent market study released by Transparency Market Research (TMR), the global prenatal and genetic testing market is estimated to be worth US$8.37 billion by 2019. TMR states that the market for prenatal and newborn testing was worth US$1.12 billion in 2012, and will exhibit exponential growth at 26.9% CAGR from 2013 to 2019. The report, titled "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", is available for sale on the company website. The research report offers detailed insights into growth opportunities of major testing procedures, key regional markets for the same, and factors influencing the global market for prenatal and newborn genetic testing.

Browse the Research Report at http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html

Prenatal and newborn genetic testing involves the use of diagnostic or screening procedures for detecting chromosomal abnormalities in a fetus or in a newborn baby. The abnormalities include: Down syndrome, Patau Syndrome, and Edward Syndrome. Prenatal testing and diagnosis enables detection of genetic abnormalities in 8 to 10 weeks of gestation and also determines the sex of the fetus.

According to the report, increase in average maternal age and late pregnancies, technological advancements in diagnostic techniques, and growing awareness about detecting genetic disorders in newborns and fetuses are the major factors driving the global prenatal and newborn genetic testing market. Worldwide, the rising number of chromosomal defects among newborns and fetuses has led to increased awareness among expectant mothers, who are increasingly undergoing such screening procedures to detect genetic abnormalities at an early stage, adds the report. As per data from Northwestern Medical Faculty Foundation, a majority of pregnant women in the U.S. undergo testing or screening for birth defects such as Down syndrome, trisomy 18, and open neural tube defects.

Avail a Sample Report Copy of Prenatal and New-born Genetic Testing Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

The market for prenatal and newborn genetic testing is primarily fueled by the increasing number of chromosomal defects among fetuses and newborns and the resultant surge in awareness among expectant mothers. With the hopes of detecting genetic abnormalities at an earlier stage, the demand for screening procedures such as genetic testing has increased. Other key factors driving the global prenatal and newborn genetic testing market include technological advancements in diagnostic techniques and rising late pregnancies and average maternal age. The prenatal and newborn genetic testing market, according to a report by Transparency Market Research, is estimated to develop at an impressive CAGR of 26.90% from 2013 to 2019, rising from a value of US$1.1 bn in 2012 to US$8.3 bn in 2019.

The report segments the global prenatal and newborn genetic testing market on two fronts: technology and geography. Based on technology, the market is divided into screening tests and diagnostic tests.The study describes techniques for diagnostic tests, which include polymerase chain reaction (PCR), array comparative genomic hybridization (aCGH), and fluorescence in-situ hybridization (FISH), while screening techniques include maternal serum and noninvasive prenatal testing (NIPT).Amongst all diagnostic tests, PCR held the largest share of the market, followed by aCGH and FISH. The growth of this segment is attributed to rising genetic diseases, combined with advantages of PCR such as procedural efficiency, high accuracy and reliability, and amplification. Among the screening tests in the market, noninvasive prenatal testing (NIPT) was registered as the largest segment, with the segment projected to exhibit the highest CAGR of all segments from 2013 to 2019 - 37.6%.

Browse Research Blog: http://www.tmrblog.com/2015/12/prenatal-new-born-genetic-testing-market.html

The global prenatal and newborn genetic testing market is segmented as follows:

Prenatal and Newborn Genetic Testing Market, by Technology 

• Diagnostic Techniques
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization &(FISH)
  • Array-Comparative Genomic Hybridization (aCGH)
• Screening Methods
  • Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)
  • Maternal Serum Screening (MSS)

Prenatal and Newborn Genetic Testing Market, by Geography 

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW) 

Trending Reports by Transparency Market Research:  

• Biotherapeutics Cell Line Development Market:  

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8272

• Regenerative Medicine Market:  

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip.S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

SOURCE Transparency Market Research